Richard C. Shelton

University of Alabama at Birmingham Hospital

Also affiliated with University of Alabama at Birmingham, AstraZeneca (Poland), University of Maryland, College Park, University of Alabama in Huntsville

MedicineNeurosciencePsychology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

1in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Papers

Driven by 7 papers. Top paper: “Comparative effectiveness research trial for antidepressant incomplete and non-responders with treatment resistant depression (ASCERTAIN-TRD) a randomized clinical trial”.

Comparative effectiveness research trial for antidepressant incomplete and non-responders with treatment resistant depression (ASCERTAIN-TRD) a randomized clinical trial

Molecular Psychiatry(2024)10.1038/s41380-024-02468-x

N/A

1.1DataRank · unranked

54 citations

Madhukar H. Trivedi, Richard C. Shelton, Dan V. Iosifescu, Michael E. Thase, Manish K. Jha +17 more

Combinatorial Pharmacogenomic Testing Improves Outcomes for Older Adults With Depression

American Journal of Geriatric Psychiatry(2020)10.1016/j.jagp.2020.05.005

N/A

0.520DataRank · unranked

31 citations

Sagar V. Parikh, Sara L. Weisenbach, Olusola Ajilore, Ipsit V. Vahia, Anthony J. Rothschild +13 more

Feasibility and acceptability of online opioid overdose education and naloxone distribution: Study protocol and preliminary results from a randomized pilot clinical trial

Contemporary Clinical Trials Communications(2023)10.1016/j.conctc.2023.101131

N/A

0.386DataRank · unranked

6 citations

Andrés Azuero, Keith R. Chichester, Matthew J. Carpenter, Michael S. Businelle, Richard C. Shelton +2 more

Psilocybin in the Treatment of Cocaine Use Disorder

JAMA Network Open(2026)10.1001/jamanetworkopen.2026.11029

N/A

0.312DataRank · unranked

7 citations

Sara N. Lappan, Richard C. Shelton, Adrienne C. Lahti, Karen L. Cropsey, Matthew W. Johnson +6 more

Childhood trauma and treatment outcomes during mood‐stabilising treatment with lithium or quetiapine among outpatients with bipolar disorder

Acta Psychiatrica Scandinavica(2022)10.1111/acps.13420

N/A

0DataRank · unranked

16 citations

Ole Köhler‐Forsberg, Louisa G. Sylvia, Samantha E. Russell, Olivia Dean, Sue Cotton +16 more

Response and remission rates during 24 weeks of mood-stabilizing treatment for bipolar depression depending on early non-response

Psychiatry Research(2021)10.1016/j.psychres.2021.114194

N/A

0DataRank · unranked

7 citations

Kirstine H. Sloth, Louisa G. Sylvia, Michael E. Thase, Joseph R. Calabrese, Mauricio Tohen +11 more

Clinical validation of combinatorial pharmacogenomic testing and single-gene guidelines in predicting psychotropic medication blood levels and clinical outcomes in patients with depression

Psychiatry Research(2020)10.1016/j.psychres.2020.113649

N/A

0DataRank · unranked

19 citations

Sagar V. Parikh, Daniel Hain, Rebecca Law, Michael E. Thase, Boadie W. Dunlop +11 more